Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical vs. Immediate Surgery for Pelvic and Sacral Osteosarcoma
NCT03360760Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of doxorubicin, cisplatin, methotrexate and ifosfamide in osteosarcoma (OS), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
doxorubicincisplatinmethotrexateifosfamide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT03360760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03360760.